Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$322M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$260M |
| 3 |
Cummins
CMI
|
+$246M |
| 4 |
Wells Fargo
WFC
|
+$242M |
| 5 |
Eli Lilly
LLY
|
+$177M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stellantis
STLA
|
+$334M |
| 2 |
RTN
Raytheon Company
RTN
|
+$310M |
| 3 |
Micron Technology
MU
|
+$306M |
| 4 |
Valero Energy
VLO
|
+$301M |
| 5 |
HF Sinclair
DINO
|
+$289M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.62% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 12.06% |
| 4 | Financials | 11.04% |
| 5 | Industrials | 10.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Usana Health Sciences
USNA
$255M
| $19.5M | 0.02% |
246,086
-36,388
| -13% | -$2.89M |
|
602
Chemed
CHE
$7.06B
| $19.4M | 0.02% |
53,759
+2,459
| +5% | +$822K |
|
603
Radian Group
RDN
$4.84B
| $19.4M | 0.02% |
847,830
+122,537
| +17% | +$2.8M |
|
604
Encompass Health
EHC
$12B
| $19.3M | 0.02% |
382,379
+20,886
| +6% | +$1.01M |
|
605
Amphenol
APH
$191B
| $19.3M | 0.02% |
802,960
+336,488
| +72% | +$8.1M |
|
606
Verisk Analytics
VRSK
$24.7B
| $19.2M | 0.02% |
131,325
+43,032
| +49% | +$6.07M |
|
|
VEDL
607
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
| $19M | 0.02% |
1,872,476
+482,731
| +35% | +$4.75M |
|
|
TCF
608
DELISTED
TCF Financial Corporation
TCF
| $18.9M | 0.02% |
908,415
-134,616
| -13% | -$2.81M |
|
|
HMSY
609
DELISTED
HMS Holdings Corp.
HMSY
| $18.9M | 0.02% |
582,409
+75,321
| +15% | +$2.3M |
|
610
Resideo Technologies
REZI
$3.04B
| $18.8M | 0.02% |
877,372
-20,955
| -2% | -$443K |
|
611
General Motors
GM
$76B
| $18.6M | 0.02% |
483,482
-203,080
| -30% | -$7.61M |
|
612
Commerce Bancshares
CBSH
$8.42B
| $18.5M | 0.02% |
436,387
-18,158
| -4% | -$766K |
|
613
Realty Income
O
$59.7B
| $18.4M | 0.02% |
275,257
+19,118
| +7% | +$1.31M |
|
614
Tandem Diabetes Care
TNDM
$1.55B
| $18.3M | 0.02% |
283,005
-53,615
| -16% | -$3.46M |
|
|
CLGX
615
DELISTED
Corelogic, Inc.
CLGX
| $18.1M | 0.02% |
433,714
-43,622
| -9% | -$1.78M |
|
|
AAN.A
616
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $18.1M | 0.02% |
296,571
+156,929
| +112% | +$9.57M |
|
617
Portland General Electric
POR
$5.82B
| $18M | 0.02% |
332,585
+68,879
| +26% | +$3.65M |
|
618
Hyatt Hotels
H
$16.9B
| $18M | 0.02% |
236,490
-383,641
| -62% | -$28.9M |
|
619
Warrior Met Coal
HCC
$5.7B
| $17.8M | 0.02% |
682,952
-145,007
| -18% | -$4.13M |
|
620
LivaNova
LIVN
$4.33B
| $17.7M | 0.02% |
246,117
+100,705
| +69% | +$7.37M |
|
|
NATI
621
DELISTED
National Instruments Corp
NATI
| $17.7M | 0.02% |
421,160
-90,545
| -18% | -$3.86M |
|
622
Evertec
EVTC
$1.79B
| $17.6M | 0.02% |
538,995
-56,059
| -9% | -$1.65M |
|
623
Signet Jewelers
SIG
$3.24B
| $17.4M | 0.02% |
973,631
-19,400
| -2% | -$417K |
|
|
WCN
624
Waste Connections
WCN
$42.9B
| $17.4M | 0.02% |
181,607
-93,478
| -34% | -$8.61M |
|
625
ZTO Express
ZTO
$16.1B
| $17.2M | 0.02% |
+897,950
| New | +$16.9M |
|
Similar funds
Cliff Asness's Q2 2019 Portfolio in Review
As of Q2 2019, Cliff Asness held 2,276 positions worth $89.6B, down 4.9% from $94.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Cliff Asness withdrew a net $5.94B in Q2 2019, closing 220 positions and reducing 1,022 holdings. Its most notable exit was Stellantis, an estimated $334M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Cliff Asness opened a new position in Optimum Communications Inc worth $28.8M.
- Cliff Asness's largest Q2 2019 buy was Optimum Communications Inc: 1,190,376 shares worth $28.8M.
- Cliff Asness added most to Procter & Gamble in Q2 2019, an estimated $322M increase.
- Cliff Asness's biggest Q2 2019 reduction was Raytheon Company, cutting an estimated $310M.
- Cliff Asness fully exited Stellantis in Q2 2019, selling an estimated $334M.
- Cliff Asness's ten largest holdings make up 13% of its $89.6B portfolio in Q2 2019.
- Cliff Asness opened 117 new positions and closed 220 in Q2 2019.
- Cliff Asness's portfolio value fell 4.9% quarter-over-quarter to $89.6B.
Based on AQR Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.